1
Sheldon Hiebert, Michael S Bowsher, Ramkumar Rajamani, Rongti Li, Paul Michael Scola: Hepatitis C virus inhibitors. Bristol Myers Squibb Company, Pamela A Mingo, Mary K VanAtten, October 22, 2013: US08563505 (2 worldwide citation)

Hepatitis C virus inhibitors having the general formula are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.


2
Sheldon Hiebert, Ramkumar Rajamani, Li Qiang Sun, Eric Mull, Eric P Gillis, Michael S Bowsher, Qian Zhao, Nicholas A Meanwell, Kishore V Renduchintala, Kandhasamy Sarkunam, Pulicharla Nagalakshmi, P V K Suresh Babu, Paul Michael Scola: Hepatitis C virus inhibitors. Bristol Myers Squibb Company, Pamela A Mingo, February 17, 2015: US08957203 (1 worldwide citation)

Hepatitis C virus inhibitors having the general formula (I) are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.


3
Sheldon Hiebert, Ramkumar Rajamani, Li Qiang Sun, Eric Mull, Eric P Gillis, Michael S Bowsher, Qian Zhao, Nicholas A Meanwell, Kishore V Renduchintala, Kandhasamy Sarkunam, Pulicharla Nagalakshmi, P V K Suresh Babu, Paul Michael Scola: Hepatitis C virus inhibitors. Bristol Myers Squibb Company, Pamela A Mingo, December 27, 2016: US09527885

Hepatitis C virus inhibitors having the general formula (I) are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.


4
Alexandre L Heureux, Sheldon Hiebert, Carol Hu, Patrick Y S Lam, John Lloyd, Zulan Pi, Jennifer X Qiao, Carl Thibeault, George O Tora, Wu Yang, Yufeng Wang, Tammy C Wang, Michael S Bowsher, Ruel Rejean: receptor, 7-hydroxy-indolinyl antagonists of P2Y. Bristol Myers Squibb Company, Barry Jacobsen, January 10, 2017: US09540323

The present invention provides compounds of Formula (I): Formula (I) as defined in the specification and compositions comprising any of such novel compounds. These compounds are antagonists of P2Y1 receptor which may be used medicaments.


5
Sheldon Hiebert, Paul Michael Scola: Hepatitis C Virus Inhibitors. Bristol Myers Squibb Company, Louis J Wille, Bristol Myers Squibb Company, October 28, 2010: US20100272674-A1

Hepatitis C virus inhibitors having the general formula (I) are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.


6
Sheldon Hiebert, Ramkumar Rajamani, Michael S Bowsher, Rongti Li, Paul Michael Scola: Hepatitis C Virus Inhibitors. Bristol Myers Squibb Company, Louis J Wille, Bristol Myers Squibb Company, April 1, 2010: US20100080770-A1

Hepatitis C virus inhibitors having the general formula are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.


7
Sheldon Hiebert, Michael S Bowsher, Ramkumar Rajamani, Rongti Li, Paul Michael Scola: Hepatitis C Virus Inhibitors. Bristol Myers Squibb Company, Louis J Wille, Bristol Myers Squibb Company, April 1, 2010: US20100080771-A1

Hepatitis C virus inhibitors having the general formula are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.